Patents Assigned to LIB Therapeutics, Inc.
  • Compositions comprising PCSK9-binding molecules and methods of use
    Patent number: 12410236
    Abstract: The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).
    Type: Grant
    Filed: May 16, 2023
    Date of Patent: September 9, 2025
    Assignee: LIB Therapeutics, Inc.
    Inventors: Tracy S. Mitchell, Richard Mealey